MOBILE VIEW  | 

BODY PACKERS

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) BODY PACKING is the act of ingesting or inserting to body orifices drug packages in order to transport them across international borders.
    B) Please refer to individual managements (e.g.; cocaine) for information on poisoning.
    C) Please refer to "COCAINE" management for further information on cocaine.
    D) Please refer to "OPIOIDS/OPIOID ANTAGONIST" management for further information on heroin or other opioids.
    E) Please refer to "PLANTS-MARIJUANA" management for further information on marijuana.
    F) Please refer to "HALLUCINOGENIC AMPHETAMINES" management for further information on ecstasy.
    G) Please refer to "HALLUCINOGENIC TRYPTAMINES" management for further information on hallucinogenic derivatives of tryptamine.
    H) Please refer to "LSD" management for further information on LSD.

Specific Substances

    A) CONSTITUENTS OF THE GROUP
    1) Couriers
    2) Higher angles
    3) Internal carriers
    4) Mules
    5) Stuffers
    6) Swallowers

Available Forms Sources

    A) FORMS
    1) PACKAGING - Packages are usually wrapped in cellophane, layers of latex, rubber cots, condoms, balloons, plastic bags, aluminum foil, plastic foil, wax sealing, carbon paper or self adhesive tape (Hollander & Hoffman, 2002; Furnari et al, 2002; Stichenwirth et al, 2000).
    2) Although the drug packets varied in size and construction in the past, they are now well crafted with a precision that suggests the use of an automated process. First, latex sheath (eg; condom or balloon) is usually used to pack drugs. The open end of this layer is tied and then covered with several other layers of latex, and sealed with a hard wax coating. To limit the risk of detection, aluminum foil, plastic food wrap, carbon paper, or other materials may be used to alter the radiodensity (Traub et al, 2003a).
    3) McCarron & Wood (1983) suggested that high-risk patients could be identified on the basis of package characteristics. They classified the cocaine packages into three types; however, this method is now obsolete, as almost all packaging are professionally packed now:
    a) TYPE 1 - Loosely packed powder in condoms, toy balloons, or the fingers of latex gloves; two to four layers of condom rubber or other latex-like material; round or cigar shaped; highly susceptible to leakage and rupture. In abdominal radiographs, type 1 packages can be readily identified. These packages may appear as well-defined, circular, white densities. In addition, they may appear as more radiolucent foreign bodies (McCarron & Wood, 1983).
    b) TYPE 2 - Multilayer tubular latex, tightly packed powder; possibly machine packaged; may be tied tightly with a smooth tie at each end. Highly stable. Less susceptible to breakage than type 1 packets. In abdominal radiographs, type 2 packages can be readily identified. These packages are similar in density to soft tissue and highlighted by a relatively regular gas halo (McCleave, 1993; McCarron & Wood, 1983).
    c) TYPE 3 - Hardened paste wrapped in aluminum foil and overwrapped with three to five layers of tubular latex securely tied at both ends; tightly packed powder. In abdominal radiographs, these smaller, very hard, and irregular-sized packages did not appear as foreign bodies. In this case series, the abdominal films were interpreted as negative in all cases. More resistant to breakage or leaching cocaine (McCarron & Wood, 1983).

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) This management will discuss the evaluation and decontamination of body packers. Please refer to the individual managements for detailed information regarding the clinical presentation, laboratory evaluation, and treatment of specific drug exposures (e.g. heroin, cocaine, etc.).
    B) BACKGROUND: The act of concealing illegal drugs in body cavities for smuggling is termed body packing. These cases involve large amounts of meticulously wrapped illegal drugs. Drugs may be packed orally (most common), vaginally or rectally. The drug is carefully packaged and the risk for rupture is low; however, massive amount of drug is packed, so leakage of packets may result in severe toxicity. Abdominal obstruction may also occur. The most commonly packed drugs are cocaine and opioids (primarily heroin), and there are occasional reports of body packing of other sympathomimetics and hallucinogens. Patients often co-ingest anticholinergic agents to slow motility through the gastrointestinal tract.
    C) PHARMACOLOGY: Refer to the individual document for pharmacology information. Packaging a drug may alter its absorption and patients may present in a delayed fashion.
    D) EPIDEMIOLOGY: The majority of these exposures are mild or asymptomatic. Most cases occur in or near major international airports.
    E) WITH POISONING/EXPOSURE
    1) TOXICITY
    a) SYMPATHOMIMETICS (PRIMARILY COCAINE): Mild overdose patients often present with mild tachycardia and hypertension. Patients with moderate to severe toxicity will often present with severe tachycardia, hypertension, hyperthermia, agitation along with aggression, seizures and cardiac dysrhythmias.
    b) OPIOIDS (PRIMARILY HEROIN): Patients with mild toxicity may present with mild CNS/respiratory depression. In moderate to severe exposures, patients will present with respiratory/CNS depression, hypoxia, hypotension, hypothermia, and respiratory failure.
    c) HALLUCINOGENIC AMPHETAMINES: In general, most cases of MDMA and MDEA toxicity result in mild symptoms that can include fatigue, difficulty concentrating, agitation, hypertension, tachycardia, mydriasis, trismus, and diaphoresis. Occasionally, intense dysphoria (depression, anxiety), confusion, or delirium can occur. Severe overdoses appear to follow a clear pattern of toxicity characterized by hyperthermia, disseminated intravascular coagulation (DIC), rhabdomyolysis, acidosis, hyperkalemia, dysrhythmias, seizures, and acute renal failure. Severe toxicity can develop after typical recreational doses. Ecstasy-associated (MDMA) morbidity and mortality have been related to hyponatremia, dehydration, hyperthermia, hypertensive crisis, and cardiac dysrhythmias.
    d) Patients may also present with signs of an anticholinergic toxidrome (mydriasis, tachycardia, decreased bowel sounds, and dry/flushed skin) as these agents are often ingested to delay the passage of packets.
    0.2.20) REPRODUCTIVE
    A) Cocaine body packing in pregnancy has caused uterine ischemia and developmental delays in the infant

Laboratory Monitoring

    A) Monitor electrolytes, CBC, CPK, and urinalysis.
    B) Perform radiography imaging including plain, barium enhanced abdominal radiographs and/or CT to document packets and removal of packets.
    C) Institute continuous cardiac monitoring and obtain serial ECGs.
    D) A negative urine drug screen does NOT rule out the possibility of body packing.

Treatment Overview

    0.4.2) ORAL/PARENTERAL EXPOSURE
    A) MANAGEMENT OF MILD TO MODERATE TOXICITY
    1) Patients who develop any signs of drug effect are at high risk for rapid deterioration. Early airway management and aggressive resuscitation should be started at the first sign of drug effect. Patients who have X-ray or CT confirmation of retained packages should be admitted to an ICU setting. Perform continuous cardiac monitoring. If the patient is awake and asymptomatic, administer oral charcoal and initiate whole bowel irrigation with polyethylene glycol (DOSE: ADULTS - 2 liters initially, then 1.5 to 2 liters per hour until rectal effluent is clear and radiography is negative. CHILDREN 6 TO 12 YEARS: 1000 mL/hour; CHILDREN 9 MONTHS TO 6 YEARS: 500 mL/hour.) to hasten the removal of packets. Patients who remain asymptomatic must be observed until all packets are passed. This usually takes 3 to 4 days. Patients can be discharged after having 2 to 3 packet-free stools and negative imaging (plain, barium enhanced abdominal radiographs or CT). There is no perfect imaging modality for detection of packages, and often a combination of modalities is necessary. CT is thought to be more accurate than radiography for detection because of improved contrast resolution. Mild to moderate sympathomimetic exposures can be treated with IV fluids and benzodiazepines. Consult the surgical team early because of the risk of rupture or obstruction. For mild to moderate opioid exposures, respiratory status should be monitored and naloxone administered if clinically indicated. A naloxone infusion may be necessary because of continued drug absorption.
    B) MANAGEMENT OF SEVERE TOXICITY
    1) Early airway management is imperative for any patient with severe toxicity. For severe sympathomimetic exposures, patients should be aggressively sedated (large doses of benzodiazepines may be necessary), and if this is not effective, patients should be paralyzed and intubated. Patients who develop wide complex dysrhythmias or cardiac arrest should be treated with sodium bicarbonate (1 to 2 mEq/kg IV repeated every 5 minutes, endpoint is arterial pH of 7.45 to 7.55). Immediately involve the surgical team for any patient with signs of packet rupture, obstruction or hemodynamic instability, because of risk for severe toxicity and gastrointestinal necrosis, especially with sympathomimetic agents. Severe toxicity from opioid overdose can be effectively reversed with naloxone boluses or an infusion titrated to reverse mental status and respiratory depression. If a patient arrives intubated, do not administer naloxone as this may precipitate withdrawal. Allow the patient to metabolize the opioid while providing meticulous symptomatic and supportive care.
    C) DECONTAMINATION
    1) PREHOSPITAL: Activated charcoal can be administered to asymptomatic patients, but the risks and benefits of administration must be weighed on a case-by-case basis. Activated charcoal adsorbs sympathomimetics and opioids effectively. Activated charcoal can be utilized in any patient who presents with normal mental status or if the airway is protected.
    2) HOSPITAL: Activated charcoal can be utilized in any patient who presents with normal mental status or if the airway is protected. Gastric lavage is contraindicated as it is usually not effective, and may perforate any packets in the stomach. Whole bowel irrigation is effective. Administer polyethylene glycol solution to patients who are alert or in whom airway is protected. DOSE: ADULTS - 2 liters initially, then 1.5 to 2 liters per hour until rectal effluent is clear and radiography is negative. CHILDREN 6 TO 12 YEARS: 1000 mL/hour; CHILDREN 9 MONTHS TO 6 YEARS: 500 mL/hour. Follow closely for electrolyte imbalance and monitor mental status and risk of aspiration.
    D) AIRWAY MANAGEMENT
    1) Intubate patients not responsive to naloxone or who are seizing, hemodynamically unstable, agitated, or obtunded.
    E) ANTIDOTE
    1) Patients who present with QRS widening or wide complex tachycardia after packing cocaine or cocaine containing products, may be treated with sodium bicarbonate (1 to 2 mEq/kg bolus; repeat as needed to maintain arterial pH between 7.45 and 7.55). Monitor acid-base status and serum sodium, as aggressive sodium bicarbonate therapy may cause alkalemia and hypernatremia. Treat seizures with benzodiazepines.
    2) Patients who develop opioid toxicity can be treated with the opioid antagonist naloxone (0.4 mg IV and titrate to effect). A naloxone infusion may be necessary due to prolonged drug absorption and can be started at 0.4 to 0.8 mg/hour in normal saline or 5% dextrose titrated to clinical effects.
    F) ENHANCED ELIMINATION
    1) The most commonly packed drugs are not effectively removed by hemodialysis or hemoperfusion.
    G) PATIENT DISPOSITION
    1) HOME CRITERIA: Body packers should never be managed at home, airport or jail.
    2) OBSERVATION CRITERIA: Patients with confirmed packets by radiography should be observed until the passage of all packets was confirmed by negative radiography (plain, barium enhanced abdominal radiographs or CT) and 2 to 3 packet-free stools; however, this is not a guarantee that all packets have passed and stool can obscure detection. The sensitivity for plain radiography is approximately 85% to 90% and thought to be higher with barium enhanced radiography or CT.
    3) ADMISSION CRITERIA: All suspected body packers should be admitted to an ICU setting because of a potential for packet rupture and the rapid deterioration of a patient.
    4) CONSULT CRITERIA: Consult a poison center or medical toxicologist for assistance in managing any symptomatic body packer. Consult with surgical team early as there is a potential for packet rupture or gastrointestinal obstruction.
    H) PITFALLS
    1) May occur when patients are not monitored closely or are discharged prematurely. Despite the inherent risks of anesthesia and surgery in patients with severe toxicity from ruptured packets, the immediate surgical intervention for removal of packets and their contents offers these patients the best chance of survival.

Range Of Toxicity

    A) TOXICITY: Body packers generally ingest or insert multiple times the lethal dose of a drug. These patients may rapidly develop life-threatening toxicity following the rupture of a packet.
    B) As many as 147 to 182 packets containing 3 to 7 grams of cocaine per packet have been described in case reports.
    C) Although the estimated minimum lethal dose of cocaine is 1.2 g, fatalities have been reported after 30 mg of cocaine applied to mucous membranes. Fatalities have been reported after the ingestion of 1 to 3 grams of cocaine in powder form.
    D) The lethal dose of opioids varies and depends on purity of the drug and the tolerance of the involved individual.

Summary Of Exposure

    A) This management will discuss the evaluation and decontamination of body packers. Please refer to the individual managements for detailed information regarding the clinical presentation, laboratory evaluation, and treatment of specific drug exposures (e.g. heroin, cocaine, etc.).
    B) BACKGROUND: The act of concealing illegal drugs in body cavities for smuggling is termed body packing. These cases involve large amounts of meticulously wrapped illegal drugs. Drugs may be packed orally (most common), vaginally or rectally. The drug is carefully packaged and the risk for rupture is low; however, massive amount of drug is packed, so leakage of packets may result in severe toxicity. Abdominal obstruction may also occur. The most commonly packed drugs are cocaine and opioids (primarily heroin), and there are occasional reports of body packing of other sympathomimetics and hallucinogens. Patients often co-ingest anticholinergic agents to slow motility through the gastrointestinal tract.
    C) PHARMACOLOGY: Refer to the individual document for pharmacology information. Packaging a drug may alter its absorption and patients may present in a delayed fashion.
    D) EPIDEMIOLOGY: The majority of these exposures are mild or asymptomatic. Most cases occur in or near major international airports.
    E) WITH POISONING/EXPOSURE
    1) TOXICITY
    a) SYMPATHOMIMETICS (PRIMARILY COCAINE): Mild overdose patients often present with mild tachycardia and hypertension. Patients with moderate to severe toxicity will often present with severe tachycardia, hypertension, hyperthermia, agitation along with aggression, seizures and cardiac dysrhythmias.
    b) OPIOIDS (PRIMARILY HEROIN): Patients with mild toxicity may present with mild CNS/respiratory depression. In moderate to severe exposures, patients will present with respiratory/CNS depression, hypoxia, hypotension, hypothermia, and respiratory failure.
    c) HALLUCINOGENIC AMPHETAMINES: In general, most cases of MDMA and MDEA toxicity result in mild symptoms that can include fatigue, difficulty concentrating, agitation, hypertension, tachycardia, mydriasis, trismus, and diaphoresis. Occasionally, intense dysphoria (depression, anxiety), confusion, or delirium can occur. Severe overdoses appear to follow a clear pattern of toxicity characterized by hyperthermia, disseminated intravascular coagulation (DIC), rhabdomyolysis, acidosis, hyperkalemia, dysrhythmias, seizures, and acute renal failure. Severe toxicity can develop after typical recreational doses. Ecstasy-associated (MDMA) morbidity and mortality have been related to hyponatremia, dehydration, hyperthermia, hypertensive crisis, and cardiac dysrhythmias.
    d) Patients may also present with signs of an anticholinergic toxidrome (mydriasis, tachycardia, decreased bowel sounds, and dry/flushed skin) as these agents are often ingested to delay the passage of packets.

Gastrointestinal

    3.8.2) CLINICAL EFFECTS
    A) INTESTINAL OBSTRUCTION
    1) Bowel obstruction and laceration and mediastinitis have been reported (Brown et al, 2002; McCleave, 1993).
    2) CASE REPORT - A 38-year-old intravenous drug abuser developed an acute small bowel obstruction secondary to an impacted intraluminal heroin balloon in the mid jejunum (Brown et al, 2002).
    3) CASE SERIES - In a series of 50 deaths in body packers in New York City, 6 patients developed bowel obstruction and/or bowel perforation, all of these cases involved opioids (Gill & Graham, 2002).
    4) In one study, 11 cases of body packers with bowel obstruction were identified. Eight of these patients had no underlying gastrointestinal abnormalities. In these patients, the most common site (n=5) of obstruction was the distal ileum (a few centimeters short of the ileocecal valve). Other sites of obstruction were the stomach (n=2), and the sigmoid colon (n=1). Three cases had underlying predisposing pathology; one with previous appendectomy and adhesions, another with Meckel's diverticulum, and one with benign distal esophageal stricture (East, 2005).
    B) RESPIRATORY OBSTRUCTION
    1) WITH POISONING/EXPOSURE
    a) One study reported 5 cases of death caused by airway obstruction by swallowed packages. In one case, aspiration of stomach contents following cocaine abuse was observed (Havis et al, 2005).

Reproductive

    3.20.1) SUMMARY
    A) Cocaine body packing in pregnancy has caused uterine ischemia and developmental delays in the infant
    3.20.3) EFFECTS IN PREGNANCY
    A) COCAINE
    1) A 26-year-old woman at 32 weeks gestation developed severe cocaine toxicity after body packing (seizures, acidosis, apnea, refractory ventricular dysrhythmias). Perimortem cesarean section was performed, and the neonate had apgar scores of 2, 4, and 5 at 1, 5 and 10 minutes respectively. At one year follow-up the child had neurodevelopmental delays. The mother died despite aggressive care; autopsy revealed uterine ischemia, and 157 packets containing 830 g cocaine, one of which had ruptured(Cordero et al, 2006).

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) Monitor electrolytes, CBC, CPK, and urinalysis.
    B) Perform radiography imaging including plain, barium enhanced abdominal radiographs and/or CT to document packets and removal of packets.
    C) Institute continuous cardiac monitoring and obtain serial ECGs.
    D) A negative urine drug screen does NOT rule out the possibility of body packing.
    4.1.2) SERUM/BLOOD
    A) BLOOD/SERUM CHEMISTRY
    1) CBC, electrolytes and urinalysis may be indicated.
    2) Cardiac monitoring is indicated in all patients.
    4.1.3) URINE
    A) URINARY LEVELS
    1) Rapid urine testing for drugs of abuse may assist in determining the packet(s) content (Nelson, 2002); however, because of the poor sensitivity (37% in one large study) of urine testing, it is not recommended as part of the routine evaluation (Traub et al, 2003a). A negative urine drug screen does NOT rule out the possibility of body packing.
    2) Monitoring of urine cocaine levels was not reliable for the determination of residual cocaine packets in a study of 30 body-packers. In 6 of 30 cases, urine levels were undetectable for 5 days before complete clearance of packets (Gherardi et al, 1988).
    3) Benzoylecgonine was detected in the urine of a husband and wife team of body packers. Urine tests remained positive until day 2 and became negative only with total clearance of packets (Gherardi et al, 1990). The asymptomatic couple swallowed 56 packets of powder wrapped in cellophane and 5 layers of latex, all tied with nonabsorbable surgical ligature.

Radiographic Studies

    A) Perform radiography imaging including plain, barium enhanced abdominal radiographs and/or CT to document packets and removal of packets.
    B) Packets have been missed on every radiographic modality and even after exploratory laparotomy and whole bowel irrigation. There is no perfect study and often a combination of studies may be required.
    C) ABDOMINAL RADIOGRAPH
    1) PLAIN ABDOMINAL RADIOGRAPH - In body packers, the packages are usually located in the small and large bowel (Hollander & Hoffman, 2002). Although abdominal radiographs may be of value in locating cocaine packets (Souka, 1999; Beerman et al, 1986), not all package types can be visualized on radiograph (Hoffman et al, 1990; McCarron & Wood, 1983). In addition, these packages may disappear from view following treatment with activated charcoal or whole-bowel irrigation (Hollander & Hoffman, 2002; Harchelroad, 1992). Radiographs must be repeated after each procedure until all packages have been removed.
    a) Plain abdominal radiograph should be taken in both the supine and the erect positions. These films may show oval or round soft tissue densities highlighted by a gas halo. These haloes may be caused by air captured in the packages during wrapping, gas passing into the condoms if the rubber is degenerating, or fermentation of the contents. If gas haloes develop during patient monitoring, it may indicate package breakdown (McCleave, 1993). Many packages are radiopaque or have a distinct radiographic characteristic. In some cases, a knot at the end of the packet may be seen as a "rosette" (Schwartz, 2002; Brown et al, 2002).
    b) Since one or two remaining packets can be difficult to visualize radiographically after whole-bowel irrigation, enteric contrast material can help detect any remaining packages (Schwartz, 2002).
    c) Approximately 85% to 90% of body packers will have positive plain abdominal radiographs (Schwartz, 1998). One study reported the sensitivity of plain abdominal radiography of 47% to 95% in body packers (Sporer & Firestone, 1997); several large series reported a sensitivity of 85% to 90%, however, sensitivity for small number of packets may be lower (Traub et al, 2003a). Abdominal radiographs have a reported false-positive rate of 3.6% and false-negative rate of 1.2% to 33% in detection of body packs, especially in the colon and when constipation is present. The presence of feces tends to obscure package visualization (Souka, 1999; McCleave, 1993).
    d) FALSE POSITIVE ABDOMINAL RADIOGRAPH - False-positive results may occur due to copious stool, especially if the patient is constipated, a recent use of gastrointestinal contrast media, or the presence of bladder stones. A body packer had a false-positive abdominal radiograph resulting from intraabdominal calcifications (Traub et al, 2003; Traub et al, 2003a).
    e) In one study of opium body packing, the diagnostic value of ultrasonography, plain x-ray and CT scanning was reviewed. Overall, 25 body packers were considered. Ultrasonography did not reveal any clear countable packets; plain abdominal x-ray showed the packets in 12 (48%) patients and abdominal CT scan was positive in 25 (96%) patients (p <0.001) (Zare & Balali-Mood, 2003).
    2) ABDOMINAL CT
    a) CT scan has been reported to be more accurate than radiography in the detection of the drug-filled bags because of its improved contrast resolution and the elimination of projections of overlapping structures. CT can also show the level and severity of an obstruction (Brown et al, 2002).
    b) Upper abdominal CT scan and abdominal radiograph with Gastrografin(R) or barium have been reported to result in better visualization (June et al, 2000; McCleave, 1993; Diamant-Berger et al, 1988; Gherardi et al, 1990; Hoffman et al, 1990; Marc et al, 1990; Hartoko et al, 1988). It is recommended that the first radiograph is taken five or more hours after ingestion of the contrast material and further radiographs should be taken daily (McCleave, 1993), and after whole bowel irrigation has been completed.
    c) Brown et al (2002) suggested that many packages in the GI may not be detected if the window width and level settings typically employed for abdominal CT (e.g., window width 350 HU, window level 50 HU) are used. In cases of suspected drug packet ingestion, these authors recommended the use of window width and level settings typically used to view lung parenchyma (e.g., window width 1000 HU, window level -700 HU) in addition to those commonly used for abdominal CT (Brown et al, 2002).
    d) In a pilot study with 5 volunteers, Hibbard et al (1999) used non-contrast spiral CT scans 2 to 4 hours after ingestion of a placebo wrapped in plastic bags to determine the effectiveness of the CT scans in visualizing the placebo. Foreign bodies, consistent with placebo, were seen in 3 out of 5 CT scans (60%). No definite foreign body was visible with the other CT scans (Hibbard et al, 1999).
    e) CASE REPORT - A 38-year-old male developed acute bowel obstruction secondary to an impacted intraluminal heroin balloon in the mid jejunum. Multiple loops of dilated proximal small bowel with air-fluid levels compatible with a proximal-to-mid small bowel obstruction were observed in the abdominal radiographs. The CT scan of the abdomen without oral or intravenous contrast medium revealed moderately dilated loops of proximal jejunum with an abrupt change in calibre in the mid-to-distal jejunum. A sharply defined, almost perfectly round gas-filled structure mimicking a bowel loop was also observed. This heroin-containing balloon seen on CT of the abdomen was not seen on plain radiographs (Brown et al, 2002).
    f) In one case report, a helical abdominal CT scan with oral contrast failed to detect a heroin packet in a body packer. An upright abdominal radiograph showed the packet in the right lower quadrant. The patient received continued WBI and ultimately passed the packet within 1 hour (Hahn et al, 2004).
    g) In one study of opium body packing, the diagnostic value of ultrasonography, plain x-ray and CT scanning was reviewed. Overall, 25 body packers were considered. Ultrasonography did not reveal any clear countable packets; plain abdominal x-ray showed the packets in 12 (48%) patients and abdominal CT scan was positive in 25 (96%) patients (p <0.001) (Zare & Balali-Mood, 2003).
    3) MRI
    a) Magnetic resonance does not visualize packets because of the lack of protons (Kersschot et al, 1985).
    4) KUB
    a) The Kidney Ureter Bladder Radiograph (KUB) is usually positive in body packers; however, KUB is often negative in body stuffers (Eng et al, 1999).
    5) ULTRASOUND
    a) Ultrasonography has not been the diagnostic modality of choice for detecting ingested drug packets (Brown et al, 2002).
    b) In one study of opium body packing, the diagnostic value of ultrasonography, plain radiographs and CT scanning was reviewed. Overall, 25 body packers were considered. Ultrasonography did not reveal any clear countable packets; plain abdominal radiograph showed the packets in 12 (48%) patients and abdominal CT scan was positive in 25 (96%) patients (p <0.001)(Zare & Balali-Mood, 2003).
    6) GENERAL-
    a) DIAGNOSTIC FINDINGS/CASE SERIES - To study the imaging characteristics of cannabis, cocaine and heroin in body packers, a retrospective analysis of the images of plain abdominal radiography, computed tomography (CT) and ultrasound (US) was performed in 23 patients. In abdominal plain radiographs and CT, cannabis and cocaine packages were observed as well-demarcated rectangular-shaped high-density shadows surrounded by gas halo ("double condom sign"). Since heroin packages resembled stool masses, they were demonstrated as obscure shadows and were difficult to identify on plain radiographs. In one cannabis patient, US was performed and packages were demonstrated as round echogenic structures with dorsal echo extinctions. The authors concluded that abdominal plain radiography, CT and US are valuable diagnostic modalities to evaluate body packers (Ichikawa et al, 1997).

Methods

    A) MULTIPLE ANALYTICAL METHODS
    1) Please refer to the individual managements (e.g., cocaine) for information on analytical methods.

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.1) DISPOSITION/ORAL EXPOSURE
    6.3.1.1) ADMISSION CRITERIA/ORAL
    A) All suspected body packers should be admitted to an ICU setting because of a potential for packet rupture and the rapid deterioration of a patient.
    6.3.1.2) HOME CRITERIA/ORAL
    A) Body packers should never be managed at home, airport or jail.
    6.3.1.3) CONSULT CRITERIA/ORAL
    A) Consult a poison center or medical toxicologist for assistance in managing any symptomatic body packer. Consult with surgical team early as there is a potential for packet rupture or gastrointestinal obstruction.
    6.3.1.5) OBSERVATION CRITERIA/ORAL
    A) Patients with confirmed packets by radiography should be observed until the passage of all packets was confirmed by negative radiography (plain, barium enhanced abdominal radiographs or CT) and 2 to 3 packet-free stools; however, this is not a guarantee that all packets have passed and stool can obscure detection. The sensitivity for plain radiography is approximately 85% to 90% and thought to be higher with barium enhanced radiography or CT.
    B) Packet counts and packet-free stools should never be used as the sole determinant that all packets have been passed (Traub et al, 2003a).

Monitoring

    A) Monitor electrolytes, CBC, CPK, and urinalysis.
    B) Perform radiography imaging including plain, barium enhanced abdominal radiographs and/or CT to document packets and removal of packets.
    C) Institute continuous cardiac monitoring and obtain serial ECGs.
    D) A negative urine drug screen does NOT rule out the possibility of body packing.

Oral Exposure

    6.5.1) PREVENTION OF ABSORPTION/PREHOSPITAL
    A) ACTIVATED CHARCOAL
    1) Activated charcoal adsorbs sympathomimetics and opioids effectively.
    2) PREHOSPITAL ACTIVATED CHARCOAL ADMINISTRATION
    a) Consider prehospital administration of activated charcoal as an aqueous slurry in patients with a potentially toxic ingestion who are awake and able to protect their airway. Activated charcoal is most effective when administered within one hour of ingestion. Administration in the prehospital setting has the potential to significantly decrease the time from toxin ingestion to activated charcoal administration, although it has not been shown to affect outcome (Alaspaa et al, 2005; Thakore & Murphy, 2002; Spiller & Rogers, 2002).
    1) In patients who are at risk for the abrupt onset of seizures or mental status depression, activated charcoal should not be administered in the prehospital setting, due to the risk of aspiration in the event of spontaneous emesis.
    2) The addition of flavoring agents (cola drinks, chocolate milk, cherry syrup) to activated charcoal improves the palatability for children and may facilitate successful administration (Guenther Skokan et al, 2001; Dagnone et al, 2002).
    3) CHARCOAL DOSE
    a) Use a minimum of 240 milliliters of water per 30 grams charcoal (FDA, 1985). Optimum dose not established; usual dose is 25 to 100 grams in adults and adolescents; 25 to 50 grams in children aged 1 to 12 years (or 0.5 to 1 gram/kilogram body weight) ; and 0.5 to 1 gram/kilogram in infants up to 1 year old (Chyka et al, 2005).
    1) Routine use of a cathartic with activated charcoal is NOT recommended as there is no evidence that cathartics reduce drug absorption and cathartics are known to cause adverse effects such as nausea, vomiting, abdominal cramps, electrolyte imbalances and occasionally hypotension (None Listed, 2004).
    b) ADVERSE EFFECTS/CONTRAINDICATIONS
    1) Complications: emesis, aspiration (Chyka et al, 2005). Aspiration may be complicated by acute respiratory failure, ARDS, bronchiolitis obliterans or chronic lung disease (Golej et al, 2001; Graff et al, 2002; Pollack et al, 1981; Harris & Filandrinos, 1993; Elliot et al, 1989; Rau et al, 1988; Golej et al, 2001; Graff et al, 2002). Refer to the ACTIVATED CHARCOAL/TREATMENT management for further information.
    2) Contraindications: unprotected airway (increases risk/severity of aspiration) , nonfunctioning gastrointestinal tract, uncontrolled vomiting, and ingestion of most hydrocarbons (Chyka et al, 2005).
    6.5.2) PREVENTION OF ABSORPTION
    A) ACTIVATED CHARCOAL
    1) Activated charcoal may adsorb cocaine leaking or leaching from cocaine packets, as well as serve as a marker for GI transit. It has been suggested that some packets are semipermeable and do not need to rupture to cause death from cocaine toxicity (Queen & Glauser, 2002; Wetli & Mittleman, 1981).
    2) Although activated charcoal has been used in body packers, its spillage into the peritoneum secondary to perforation of the bowel wall or during surgery is of concern (Olmedo et al, 2001).
    3) CHARCOAL ADMINISTRATION
    a) Consider administration of activated charcoal after a potentially toxic ingestion (Chyka et al, 2005). Administer charcoal as an aqueous slurry; most effective when administered within one hour of ingestion.
    4) CHARCOAL DOSE
    a) Use a minimum of 240 milliliters of water per 30 grams charcoal (FDA, 1985). Optimum dose not established; usual dose is 25 to 100 grams in adults and adolescents; 25 to 50 grams in children aged 1 to 12 years (or 0.5 to 1 gram/kilogram body weight) ; and 0.5 to 1 gram/kilogram in infants up to 1 year old (Chyka et al, 2005).
    1) Routine use of a cathartic with activated charcoal is NOT recommended as there is no evidence that cathartics reduce drug absorption and cathartics are known to cause adverse effects such as nausea, vomiting, abdominal cramps, electrolyte imbalances and occasionally hypotension (None Listed, 2004).
    b) ADVERSE EFFECTS/CONTRAINDICATIONS
    1) Complications: emesis, aspiration (Chyka et al, 2005). Aspiration may be complicated by acute respiratory failure, ARDS, bronchiolitis obliterans or chronic lung disease (Golej et al, 2001; Graff et al, 2002; Pollack et al, 1981; Harris & Filandrinos, 1993; Elliot et al, 1989; Rau et al, 1988; Golej et al, 2001; Graff et al, 2002). Refer to the ACTIVATED CHARCOAL/TREATMENT management for further information.
    2) Contraindications: unprotected airway (increases risk/severity of aspiration) , nonfunctioning gastrointestinal tract, uncontrolled vomiting, and ingestion of most hydrocarbons (Chyka et al, 2005).
    B) WHOLE BOWEL IRRIGATION (WBI)
    1) WHOLE BOWEL IRRIGATION may be a relatively safe and effective means of rapid decontamination for the asymptomatic body packer (Olmedo et al, 2001; Betzelos & Mueller, 1991; Hoffman et al, 1990). Activated charcoal should be administered prior to beginning whole bowel irrigation as polyethylene glycol (PEG) solution decreased the ability of charcoal to adsorb drug in vitro (Makosiej et al, 1993).
    2) In vitro, cocaine is rapidly hydrolyzed to benzoylecgonine at a pH above 7.4 (Aks et al, 1992). Polyethylene glycol solutions have a pH of 8 and enhance transit from the stomach to the alkaline small intestine, thus potentially diminishing cocaine absorption from leaking packets.
    3) However, as benzoylecgonine is not pharmacologically inactive (Brogan et al, 1992; Kurth et al, 1993), it is not clear what clinical effect the intraintestinal hydrolysis of cocaine would have (Konkol & Olsen, 1993).
    4) One study reported that WBI with PEG used to treat contraband body packers had no higher complication frequency than other reported methods. There was no correlation between the mean length of hospital stay and either PEG dose, drug type, packet quantity, or packet weight (Farmer & Chan, 2003).
    a) WHOLE BOWEL IRRIGATION/INDICATIONS: Whole bowel irrigation with a polyethylene glycol balanced electrolyte solution appears to be a safe means of gastrointestinal decontamination. It is particularly useful when sustained release or enteric coated formulations, substances not adsorbed by activated charcoal, or substances known to form concretions or bezoars are involved in the overdose.
    1) Volunteer studies have shown significant decreases in the bioavailability of ingested drugs after whole bowel irrigation (Tenenbein et al, 1987; Kirshenbaum et al, 1989; Smith et al, 1991). There are no controlled clinical trials evaluating the efficacy of whole bowel irrigation in overdose.
    b) CONTRAINDICATIONS: This procedure should not be used in patients who are currently or are at risk for rapidly becoming obtunded, comatose, or seizing until the airway is secured by endotracheal intubation. Whole bowel irrigation should not be used in patients with bowel obstruction, bowel perforation, megacolon, ileus, uncontrolled vomiting, significant gastrointestinal bleeding, hemodynamic instability or inability to protect the airway (Tenenbein et al, 1987).
    c) ADMINISTRATION: Polyethylene glycol balanced electrolyte solution (e.g. Colyte(R), Golytely(R)) is taken orally or by nasogastric tube. The patient should be seated and/or the head of the bed elevated to at least a 45 degree angle (Tenenbein et al, 1987). Optimum dose not established. ADULT: 2 liters initially followed by 1.5 to 2 liters per hour. CHILDREN 6 to 12 years: 1000 milliliters/hour. CHILDREN 9 months to 6 years: 500 milliliters/hour. Continue until rectal effluent is clear and there is no radiographic evidence of toxin in the gastrointestinal tract.
    d) ADVERSE EFFECTS: Include nausea, vomiting, abdominal cramping, and bloating. Fluid and electrolyte status should be monitored, although severe fluid and electrolyte abnormalities have not been reported, minor electrolyte abnormalities may develop. Prolonged periods of irrigation may produce a mild metabolic acidosis. Patients with compromised airway protection are at risk for aspiration.
    6) CASE REPORT - One patient presented with opiate intoxication after swallowing packets wrapped only in electrical tape. He received activated charcoal and polyethylene glycol (PEG) solution and subsequently developed severe opiate intoxication and pulmonary edema. Endoscopy revealed empty packets in the stomach. The authors postulate that PEG may have increased the solubility of the heroin and diminished its adsorption to charcoal (Utecht et al, 1993).
    C) PROMOTILITY AGENTS
    1) Two body packers received promotility agents, erythromycin (250 mg IV ) and metoclopramide (10 mg IV), and successfully passed drug packets. In one body packer, the use of promotility agents resulted in the passage of a packet that had not progressed after 18 hours of WBI therapy. Promotility agents therapy is absolutely contraindicated in patients with gastrointestinal obstruction (Traub et al, 2003a).
    D) SURGICAL THERAPY
    1) Surgery is probably unnecessary unless the cocaine body packer becomes toxic or has bowel obstruction. Most patients can be managed with whole bowel irrigation, charcoal and observation (Silverberg et al, 2006; Souka, 1999; Caruana et al, 1984; McCarron & Wood, 1983). Intra-abdominal surgery is indicated if bowel obstruction is present or if abdominal radiography shows residual packets remaining in the gastrointestinal tract not removed by WBI (Peake et al, 2009; Queen & Glauser, 2002; Olmedo et al, 2001; Hollander & Hoffman, 2002; Olmedo et al, 1999; Souka, 1999). The clinician should be aware that surgery may fail to detect intraluminal drug packets (Olmedo et al, 2001; McCleave, 1993).
    2) According to a retrospective review of 4,660 cocaine body packers detected at the Paris and Frankfurt/Main International Airports from 1985 to 2002, 64 cocaine body packers became symptomatic due to rupture of the packets. Of these 64 symptomatic body packers, 20 underwent emergency surgery with a 100% survival rate and no major complications. The other 44 body packers died before they could be treated (Schaper et al, 2007).
    3) Follow-up plain radiography and a barium swallow with small bowel follow-through, or abdominal CT scan should be performed in all patients (Peake et al, 2009; Traub et al, 2003a; Hollander & Hoffman, 2002; Olmedo et al, 2001).
    4) Heroin body packers may be initially managed nonsurgically using WBI and continuous-infusion naloxone. Surgery should be performed if the body packer has bowel obstruction (Silverberg et al, 2006; Nelson, 2002; Olmedo et al, 2001).
    E) ENDOSCOPY
    1) Attempts at endoscopic removal have resulted in spontaneous rupture of packets and this procedure is NOT RECOMMENDED (Peake et al, 2009; Silverberg et al, 2006; Queen & Glauser, 2002; McCleave, 1993; Suarez et al, 1977), although in certain circumstances it may be "cautiously attempted" (Hoffman et al, 1990; Sherman & Zingler, 1990), particularly if the packet will not pass through the pylorus (Peake et al, 2009). The use of fiberoptic gastroduodenoscopy to remove drug-filled packets has produced mixed results (Olmedo et al, 2001).
    F) CATHARTICS
    1) Although the use of oil-based laxatives is occasionally recommended, they should not be used; these laxatives reduce the tensile strength and "burst" volume of latex products (Traub et al, 2003a).
    2) Liquid paraffin or mineral oil may dissolve latex packets and should be avoided (Visser et al, 1998; McCleave, 1993).
    3) To avoid possible package rupture or deterioration, gentle laxatives which do not directly stimulate the bowel have been used, but are not routinely recommended (McCleave, 1993). Psyllium, sodium sulfate, and bisacodyl suppositories have been used but are not generally recommended (Queen & Glauser, 2002).
    4) Care must be taken not to perforate drug packets which might be in the rectum.
    5) CASE SERIES: Utecht et al (1992) presented a series of 14 patients, nine of whom swallowed heroin-containing packets and five of whom inserted them rectally. Thirteen had evidence of packets on KUB. Bisacodyl suppositories were used to evacuate packets from the rectum. No patient received gastric lavage (Utecht et al, 1993).
    G) BRONCHOSCOPY
    1) Cobaugh et al (1997) reported a successful bronchoscopic removal of a cocaine balloon after aspiration (Cobaugh et al, 1997).
    H) ENEMAS/NOT RECOMMENDED
    1) Tap water enemas have also resulted in package rupture (Queen & Glauser, 2002; Jonsson et al, 1983); enemas should be avoided (Souka, 1999; McCleave, 1993).
    6.5.3) TREATMENT
    A) MONITORING OF PATIENT
    1) Monitor electrolytes, CBC, CPK, and urinalysis.
    2) Perform radiography imaging including plain, barium enhanced abdominal radiographs and/or CT to document packets and removal of packets.
    3) Institute continuous cardiac monitoring and obtain serial ECGs.
    4) A negative urine drug screen does NOT rule out the possibility of body packing.

Enhanced Elimination

    A) HEMODIALYSIS OR HEMOPERFUSION
    1) The most commonly packed drugs are not effectively removed by hemodialysis or hemoperfusion.
    B) PLASMA EXCHANGE
    1) CASE REPORT: Plasma exchange with fresh frozen plasma was initiated on day 1 in a 51-year-old woman who presented to the emergency department following ingestion of packets, later determined to contain cocaine contaminated with tetramisole, and subsequently developed seizures, coma, cardiac arrest, hypotension refractory to fluids and managed with vasopressors, and rhabdomyolysis. A total of 4 cycles of plasma exchange were completed, with each cycle undergoing approximately 3000 mL substitution. Following the first cycle, the patient's hemodynamic status improved and vasopressor therapy was discontinued (Giuliani et al, 2012).

Summary

    A) TOXICITY: Body packers generally ingest or insert multiple times the lethal dose of a drug. These patients may rapidly develop life-threatening toxicity following the rupture of a packet.
    B) As many as 147 to 182 packets containing 3 to 7 grams of cocaine per packet have been described in case reports.
    C) Although the estimated minimum lethal dose of cocaine is 1.2 g, fatalities have been reported after 30 mg of cocaine applied to mucous membranes. Fatalities have been reported after the ingestion of 1 to 3 grams of cocaine in powder form.
    D) The lethal dose of opioids varies and depends on purity of the drug and the tolerance of the involved individual.

Minimum Lethal Exposure

    A) GENERAL
    1) Although the estimated minimum lethal dose of cocaine is 1.2 g, fatalities have been reported after 30 mg of cocaine applied to mucous membranes (Fineschi et al, 2002).
    2) Fatalities have been reported after the ingestion of 1 to 3 grams of cocaine in powder form (McCarron & Wood, 1983).
    3) In a fatal case of cocaine poisoning in a body packer, 99 packages of cocaine (10 grams each) were recovered during autopsy; 95 of them were still intact (Furnari et al, 2002).
    4) Stichenwirth et al (2002) reported a suicide of a body packer by re-ingesting the content of 8 excreted cocaine packages (10 grams each) (Stichenwirth et al, 2000).
    5) AUTOPSY RESULTS - During an autopsy of a body packer, two inflated packages were recovered. It is suggested that the larger package contained acid liquid (it was probably inflated by gastric acid), and the smaller package was filled with alkaline liquid (it was probably inflated by duodenal fluid) (Furnari et al, 2001).

Maximum Tolerated Exposure

    A) GENERAL
    1) Body packers may swallow several packages, each containing 3 to 15 grams of cocaine hydrochloride (85% to 99% pure) and may be adulterated with lidocaine 1% to 15% (Queen & Glauser, 2002; Olmedo et al, 2001; McCarron & Wood, 1983).
    2) In several reports, body packers have ingested as many as 143 to 182 packets containing 3 to 7 grams of cocaine per packet (Queen & Glauser, 2002; McCleave, 1993).

General Bibliography

    1) Aks SE, Vander Hoek TL, & Hryhorczuk DO: Cocaine liberation from body packets in an in vitro model. Ann Emerg Med 1992; 21:1321-1325.
    2) Alaspaa AO, Kuisma MJ, Hoppu K, et al: Out-of-hospital administration of activated charcoal by emergency medical services. Ann Emerg Med 2005; 45:207-12.
    3) Beerman R, Nunez D Jr, & Wetli CV: Radiographic evaluation of the cocaine smuggler. Gastrointest Radiol 1986; 11:351-354.
    4) Beno S, Calello D, Baluffi A, et al: Pediatric body packing. Drug smuggling reaches a new low. Pediatric Emerg care 2005; 21(11):744-746.
    5) Betzelos S & Mueller P: Whole bowel irrigation in a heroin body-packer (Abstract). Vet Hum Toxicol 1991; 33:353.
    6) Brogan WC III, Lange RA, & Glamann DB: Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Ann Intern Med 1992; 116:556-561.
    7) Brown JA, Phang T, & Enns R: Computed tomography to detect body packing: an unusual cause of small bowel obstruction. Can Assoc Radiol 2002; 53(2):84-86.
    8) Caruana DS, Weinbach B, & Goerg D: Cocaine-packet ingestion. Ann Intern Med 1984; 100:73-74.
    9) Chyka PA, Seger D, Krenzelok EP, et al: Position paper: Single-dose activated charcoal. Clin Toxicol (Phila) 2005; 43(2):61-87.
    10) Cobaugh DJ, Schneider SM, & Benitez JG: Cocaine balloon aspiration: successful removal with bronchoscopy. Am J Emerg Med 1997; 15:544-546.
    11) Cordero DR, Medina C, & Helfgott A: Cocaine body packing in pregnancy. Ann Emerg Med 2006; 48(3):323-325.
    12) Dagnone D, Matsui D, & Rieder MJ: Assessment of the palatability of vehicles for activated charcoal in pediatric volunteers. Pediatr Emerg Care 2002; 18:19-21.
    13) Diamant-Berger O, Gherardi R, & Baud F: Intracorporeal concealment of narcotics. Experience at the medico-judical emergency center of the Hotel-Dieu hospital: one hundred cases. Presse Med 1988; 17:107-109.
    14) East JM: Surgical complications of cocaine body-packing. A survey of Jamaican Hospitals. West Indian Med J 2005; 54(1):38-41.
    15) Elliot CG, Colby TV, & Kelly TM: Charcoal lung. Bronchiolitis obliterans after aspiration of activated charcoal. Chest 1989; 96:672-674.
    16) Eng JG, Aks SE, & Waldron R: False-negative abdominal CT scan in a cocaine body stuffer. Am J Emerg Med 1999; 17(7):702-704.
    17) FDA: Poison treatment drug product for over-the-counter human use; tentative final monograph. FDA: Fed Register 1985; 50:2244-2262.
    18) Farmer JW & Chan SB: Whole body irrigation for contraband bodypackers. J Clin Gastroenterol 2003; 37(2):147-150.
    19) Fineschi V, Centini F, & Monciotti F: The cocaine "body stuffer" syndrome: a fatal case. Forensic Sci Int 2002; 126:7-10.
    20) Furnari C, Ottaviano V, & Sacchetti G: A fatal case of cocaine poisoning in a body packer. J Forensic Sci 2002; 47(1):208-210.
    21) Gherardi R, Marc B, & Alberti X: A cocaine body packer with normal abdominal plain radiograms. Value of drug detection in urine and contrast study of the bowel. Am J Forensic Med Pathol 1990; 11(2):154-157.
    22) Gherardi RK, Baud FJ, & Leporc P: Detection of drugs in the urine of body-packers. Lancet 1988; 1:1076-1078.
    23) Gill JR & Graham SM: Teh years of "body packers" in City: 50 deaths. J Forensic Sci 2002; 47:843-846.
    24) Giuliani E, Albertini G, Vaccari C, et al: Multi-organ failure following severe cocaine-tetramisole intoxication in a body-packer. Anaesth Intensive Care 2012; 40(3):562-564.
    25) Golej J, Boigner H, Burda G, et al: Severe respiratory failure following charcoal application in a toddler. Resuscitation 2001; 49:315-318.
    26) Graff GR, Stark J, & Berkenbosch JW: Chronic lung disease after activated charcoal aspiration. Pediatrics 2002; 109:959-961.
    27) Greenberg MI & Shrethra M: Management of the pregnant body packer (abstract). American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 2000; 38:176-177.
    28) Guenther Skokan E, Junkins EP, & Corneli HM: Taste test: children rate flavoring agents used with activated charcoal. Arch Pediatr Adolesc Med 2001; 155:683-686.
    29) Hahn IH, Hoffman rs, & Nelson LS: Contrast CT scan fails to detect the last heroin packet. J Emerg Med 2004; 27(3):279-283.
    30) Harchelroad F: Identification of orally ingested cocaine by CT scan (Abstract). Vet Human Toxicol 1992; 34:350.
    31) Harris CR & Filandrinos D: Accidental administration of activated charcoal into the lung: aspiration by proxy. Ann Emerg Med 1993; 22:1470-1473.
    32) Hartoko TJ, Demey HE, & De Schepper AMA: The body packer syndrome-cocaine smuggling in the gastro-intestinal tract. Klin Wochenschr 1988; 66:1116-1120.
    33) Havis S, Best D, & Carter J: Concealment of drugs by police detainees: lessons learned from adverse incidents and from 'routine' clinical practice. J Clin Forensic Med 2005; 12(5):237-241.
    34) Hibbard R, Wahl M, & Kirshenbaum M: Spiral CT imaging of ingested foreign bodies wrapped in plastic: a pilot study designed to mimic cocaine bodystuffers (abstract). J Toxicol-Clin Toxicol 1999; 37:644.
    35) Hoffman RS, Chiang WK, & Weisman RS: Prospective evaluation of "crack-vial" ingestions. Vet Hum Toxicol 1990; 32(2):164-167.
    36) Hollander JE & Hoffman RS: Cocaine. In: Goldfrank LR, Flomenbaum NE, Levin NA et al (eds). Goldfrank's Toxicologic Emergencies, 7th ed, McGraw-Hill, Medical Publishing Division, New York, NY, 2002.
    37) Ichikawa K, Tajima N, & Tajima H: [Diagnostic imaging of "body packers"]. Nippon Igaku Hoshasen Gakkai Zasshi 1997; 57(3):89-93.
    38) Jones OM & Shorey BA: Body packers: grading of risk as a guide to management and intervention. Ann R Coll Surg Engl 2002; 84(2):131-132.
    39) Jonsson S, O'Meara M, & Young JB: Acute cocaine poisoning: Importance of treating seizures and acidosis. Am J Med 1983; 75:1061-1064.
    40) June R, Aks SE, & Keys N: Medical outcome of cocaine bodystuffers. J Emerg Med 2000; 18(2):221-224.
    41) Kersschot E, Beaucourt L, & Degryse H: Roentgenographical detection of cocaine smuggling in the alimentary tract. Forthschr Rontgenstri 1985; 42:295-298.
    42) Kirshenbaum LA, Mathews SC, & Sitar DS: Whole-bowel irrigation versus activated charcoal in sorbitol for the ingestion of modified-release pharmaceuticals. Clin Pharmacol Ther 1989; 46:264-271.
    43) Konkol RJ & Olsen GD: Gastric alkalinization in the treatment of cocaine toxicity (Letter). Ann Emerg Med 1993; 22:166-167.
    44) Kurth CD, Monitto C, & Albuquerque ML: Cocaine and its metabolites constrict cerebral arterioles in newborn pigs. J Pharmacol Exp Ther 1993; 265:587-591.
    45) Makosiej FJ, Hoffman RS, & Howland MA: An in vitro evaluation of cocaine hydrochloride absorption by activated charcoal and desorption upon addition of polyethylene glycol electrolyte lavage solution. Clin Toxicol 1993; 31:381-395.
    46) Marc B, Baud FJ, & Aelion MJ: The cocaine body-packer syndrome: evaluation of a method of contrast study of the bowel. J Forens Sci 1990; 35:345-355.
    47) McCarron MM & Wood JD: The cocaine 'body packer' syndrome. Diagnosis and treatment. JAMA 1983; 250(11):1417-1420.
    48) McCleave NR: Drug smuggling by body packers. Detection and removal of internally concealed drugs. Med J Aust 1993; 159:750-754.
    49) Nelson LS: Opioids. In: Goldfrank LR, Howland MA, Flomenbaum NE et al (eds). Goldfrank's Toxicologic Emergencies, 7th ed, McGraw-Hill, Medical Publishing Division, New York, NY, 2002.
    50) None Listed: Position paper: cathartics. J Toxicol Clin Toxicol 2004; 42(3):243-253.
    51) Olmedo RE, Hoffman RS, & Nelson LS: Limitations of whole bowel irrigation and laparotomy in a cocaine "body-packer" (abstract). J Toxicol-Clin Toxicol 1999; 37:645.
    52) Olmedo RE, Nelson L, & Chu J: Is surgical decontamination definitive treatment of "body-packers"?. Am J Emerg Med 2001; 19:593-596.
    53) Peake ST, Das S, Greene S, et al: Cocaine 'body packers' and the clinical management of packet rupture. Br J Hosp Med (Lond) 2009; 70(2):110-111.
    54) Pollack MM, Dunbar BS, & Holbrook PR: Aspiration of activated charcoal and gastric contents. Ann Emerg Med 1981; 10:528-529.
    55) Queen JR & Glauser J: A young man with hyperthermia and new-onset seizures. Cleveland Clin Journal Med 2002; 69(6):453-466.
    56) Rau NR, Nagaraj MV, Prakash PS, et al: Fatal pulmonary aspiration of oral activated charcoal. Br Med J 1988; 297:918-919.
    57) Schaper A , Hofmann R , Bargain P , et al: Surgical treatment in cocaine body packers and body pushers. Int J Colorectal Dis 2007; 22(12):1531-1535.
    58) Schwartz DT: Diagnostic imaging in Toxicology. In: Goldfrank LR, Flomenbaum NE, Levin NA et al (eds). Goldfrank's Toxicologic Emergencies, 7th ed, McGraw-Hill, Medical Publishing Division, New York, NY, 2002.
    59) Schwartz DT: Diagnostic imaging in Toxicology. In: Goldfrank LR, Howland MA, Flomenbaum NE et al (eds). Goldfrank's Toxicologic Emergencies, 6th ed, McGraw-Hill, Medical Publishing Division, New York, NY, 1998.
    60) Sherman A & Zingler BM: Successful endoscopic retrieval of a cocaine packet from the stomach. Gastrointest Endosc 1990; 36:152-154.
    61) Silverberg D, Menes T, & Kim U: Surgery for "body packers": a 15-year experience. World J Surg 2006; 30(4):541-546.
    62) Smith SW, Ling LJ, & Halstenson CE: Whole-bowel irrigation as a treatment for acute lithium overdose. Ann Emerg Med 1991; 20:536-539.
    63) Souka HM: Body packers. Saudi Med J 1999; 20:845-847.
    64) Spiller HA & Rogers GC: Evaluation of administration of activated charcoal in the home. Pediatrics 2002; 108:E100.
    65) Sporer KA & Firestone J: Clinical course of crack cocaine body stuffers. Ann Emerg Med 1997; 29(5):596-601.
    66) Stichenwirth M, Stelwag-Carion C, & Klupp N: Suicide of a body packer. Forensic Sci Int 2000; 108:61-66.
    67) Suarez C, Arango A, & Lester L: Cocaine-condom ingestion. JAMA 1977; 238:1391-1392.
    68) Takekawa K, Ohmori T, Kido A, et al: Methamphetamine body packer: acute poisoning death due to massive leaking of methamphetamine. J Forensic Sci 2007; 52(5):1219-1222.
    69) Tenenbein M, Cohen S, & Sitar DS: Whole bowel irrigation as a decontamination procedure after acute drug overdose. Arch Int Med 1987; 147:905-907.
    70) Thakore S & Murphy N: The potential role of prehospital administration of activated charcoal. Emerg Med J 2002; 19:63-65.
    71) Traub SJ, Hoffman RS, & Nelson LS: Body packing -- the internal concealment of illicit drugs. New Engl J Med 2003a; 349:2519-2526.
    72) Traub SJ, Hoffman RS, & Nelson LS: False-positive abdominal radiography in a body packer resulting from intraabdominal calcifications. Am J Emerg Med 2003; 21(7):607-608.
    73) Traub SJ, Kohn GL, Hoffman RS, et al: Pediatric "body packing". Arch Pediatr Adolesc Med 2003b; 157:174-177.
    74) Traub SJ, Su M, Hoffman RS, et al: Use of pharmaceutical promotility agents in the treatment of body packers. Am J Emerg Med 2003a; 21(6):511-512.
    75) Utecht MJ, Stone AF, & McCarron MM: Heroin body packers. J Emerg Med 1993; 11:33-40.
    76) Visser L, Stricker B, & Hooogendoorn M: Do not give paraffin to packers. Lancet 1998; 352:1352.
    77) Wetli CV & Mittleman RE: The "body packer syndrome" -- toxicity following ingestion of illicit drugs packaged for transportation. J Forens Sci 1981; 26:492-500.
    78) Zare GA & Balali-Mood M: Diagnosis of opium body packing by plain x-ray and CT scanning (abstract). American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 2003; 41(4):539-540.
    79) de Prost N, Lefebvre A, Questel F, et al: Prognosis of cocaine body-packers. Intensive Care Med 2005; 31:955-958.